Document is current
Any future updates will be listed below
-
Authors
Terrones-Campos, Cynthia
Gallardo-Pizarro, Antonio
Martinez-Urrea, Ana
Castiella, Ainhoa
Vergara, Andrea
Gonzalez, Azucena
Egri, Natalia
Garcia-Vidal, Carolina
-
Funding
Funding for this research was provided by:
Agencia de Gestión de Ayudas Universitarias y de Investigación de Catalunya (SGR 01324 Q5856414G)
- License Information
-
More Information
Article History
Received: 1 October 2025
Accepted: 14 November 2025
First Online: 5 January 2026
Change Date: 28 February 2026
Change Type: Update
Change Details: The incorrect affiliation 4 was given in the published article due to an error by the publisher, this article has been updated.
Declarations
:
: Not applicable.
: Not applicable.
: CG-V has received honoraria for talks on behalf of Gilead Science, MSD, Pfizer, Shionogi, AbbVie, Advanz Pharma, and a grant support from Gilead Science, and Mudipharma. AS has received honoraria for talks and advisory boards from Merck Sharp and Dohme, Pfizer, Shionogi, Novartis, Angelini and Menarini as well as grant support from Pfizer and Gilead Sciences.
